Maghuyop, Shiela .

HRN: 24-91-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2024
AMPICILLIN 1GM (VIAL)
06/11/2024
06/17/2024
IVT
2g
Q6hrs
Prom X 14hrs
Waiting Final Action 
06/14/2024
CEFUROXIME 1.5GM (VIAL)
06/14/2024
06/17/2024
IV
1.5
Q8
Stat CS
Waiting Final Action 
06/14/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/14/2024
06/17/2024
IV
500mg
Q8
Stat CS
Waiting Final Action 
06/14/2024
CEFUROXIME 1.5GM (VIAL)
06/14/2024
06/17/2024
IV
1.5
Q8
S/p Primary CS
Waiting Final Action 
06/14/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/14/2024
06/17/2024
IV
500
Q8
S/p Primary CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: